Altimmune Inc (3G0) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.00K	26.00K	-	-
Cost of goods sold	14.96M	18.41M	15.48M	17.86M
Cost of revenue	14.96M	18.41M	15.48M	17.86M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.90M	10.51M	8.05M	7.57M
Operating expense	5.90M	10.51M	8.05M	7.57M
Total operating expenses	20.86M	28.92M	23.54M	25.43M
Operating income	-20.86M	-28.89M	-23.54M	-25.43M
Other non operating income	-86.00K	-27.00K	-152.00K	-25.00K
EBT including unusual items	-19.01M	-27.36M	-22.56M	-22.82M
EBT excluding unusual items	-19.01M	-27.36M	-21.85M	-22.02M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-19.01M	-27.36M	-22.56M	-22.82M
Net profit margin	-380,280.00%	-105,223.08%	-	-
Earnings per share	-0.21	-0.27	-0.18	-0.12
Interest and investment income	2.43M	2.44M	2.90M	4.53M
Interest expense	-495.00K	-876.00K	-1.07M	-1.10M
Net interest expenses	1.93M	1.56M	1.83M	3.43M
Depreciation and amortization charges	-	-	-	-
EBITDA	-20.83M	-28.87M	-23.51M	-25.41M
Gain or loss from assets sale	-	-	-	-

Finance